Active, not recruitingNCT06587074
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Russian Cardiology Research and Production Center
- Principal Investigator
- Tamila V Martyunuk, YesRussian National Cardiology Research Center
- Enrollment
- 150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Russian National Cardilogy Reasearch Center, Moscow, Russia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06587074 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06850792imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNceUniversity of Sao Paulo General Hospital
- RECRUITINGNCT05462574Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)Vanderbilt University Medical Center
See all trials for Heritable pulmonary arterial hypertension →